Metsä Board Oyj (METSA.HE)

Negative revenue growth while STERV.HE stands at 2.71%. Joel Greenblatt would look for strategic missteps or cyclical reasons.

Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.

Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.

Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.

Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.

Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.

Diluted share count expanding well above STERV.HE's 0.01%. Michael Burry would fear significant dilution to existing owners' stakes.

Dividend reduction while STERV.HE stands at 836.39%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.

Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.

Negative 5Y CAGR while STERV.HE stands at 14.76%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.

Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.

Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.

Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.

Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.

Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.

Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.

Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.

10Y equity/share CAGR at 50-75% of STERV.HE's 102.26%. Martin Whitman would note a lag in capital accumulation vs. the competitor.

5Y equity/share CAGR at 75-90% of STERV.HE's 39.44%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.

Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.

Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.

Negative near-term dividend growth while STERV.HE invests at 37.33%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.

Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.

Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.

Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.